|
2026
|
P/S
|
Pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for... |
|
|
P/S
|
Pharmaceutical preparations; medicines for human purposes. |
|
|
Invention
|
Triazine compound salt, crystal form thereof, and production method therefor. The present inventi... |
|
2025
|
Invention
|
Novel polymer containing 1,2-diamine unit, method for producing same, and use of same as reactant... |
|
|
Invention
|
Triazine compound salt, crystal form thereof, and production method therefor.
The present invent... |
|
|
Invention
|
Pharmaceutical composition for hailey-hailey disease and use thereof.
A pharmaceutical compositi... |
|
|
Invention
|
Pharmaceutical composition for keratosis and use thereof. A pharmaceutical composition for kerato... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for
treatment of erythropoietic protopo... |
|
|
P/S
|
Pharmaceutical preparations for treatment of erythropoietic protoporphyria and X-linked protoporp... |
|
|
P/S
|
Pharmaceutical preparations; medicines for human purposes. |
|
|
P/S
|
Pharmaceutical preparations, namely, targeted protein degrader for the treatment, prevention and ... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceuticals; medicines for
human purposes; targeted protein deg... |
|
|
Invention
|
Use of melanocortin-1 receptor agonist. A medicament for treatment or prevention of interstitial ... |
|
2024
|
Invention
|
Process for producing triazine compound |
|
|
Invention
|
Crystal of pyrrolidine compound.
The present invention provides a crystal of 1-{2-[(3S, 4R)-1-[(... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of Parkinson’s disease. |
|
2023
|
P/S
|
Pharmaceutical preparations for the treatment of parkinsons disease |
|
|
P/S
|
Downloadable software for detecting symptoms of ALS; Downloadable software for measuring progress... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of Parkinson's disease. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of Parkinson's disease |
|
|
P/S
|
Pharmaceutical preparations for the treatment of parkinson's disease |
|
|
P/S
|
Pharmaceutical preparations for the treatment of Parkinson's disease |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Injectable pharmaceuticals. |
|
|
P/S
|
Medicinal preparations in the form of capsules. |
|
|
Invention
|
Compounds and their use.
The specification generally relates to compounds of Formula (I), and ph... |
|
|
Invention
|
Methods of treating hypertension by periodic suppression of aldosterone synthase.
This invention... |
|
2022
|
P/S
|
Providing medical information about Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyr... |
|
2021
|
P/S
|
Pharmaceutical preparations for the treatment of central nervous system diseases, namely amyotrop... |
|
|
Invention
|
Compounds and their use. 5 have the meanings defined herein. Such compounds are modulators of RXF... |
|
|
Invention
|
Neuromuscular disease evaluation system.
A neuromuscular disease evaluation device that is less ... |
|
|
P/S
|
Pharmaceutical preparations for treatment of porphyrin metabolism disorders; pharmaceutical prepa... |
|
|
P/S
|
Pharmaceutical preparations for treatment of porphyrin
metabolism disorders; pharmaceutical prep... |
|
|
Invention
|
Prophylactic or therapeutic agent for porphyria. A medicament for treatment or prevention of porp... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of Parkinson's disease. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of Parkinson's
disease. |
|
|
P/S
|
Pharmaceutical preparations; medicines for human purposes;
pharmaceutical preparations for the t... |
|
|
Invention
|
Pharmaceutical composition.
A pharmaceutical composition of 2-amino-2-[2-(4-heptyloxy-3-trifluor... |
|
2019
|
Invention
|
Crystal of pyrrolidine compound. The present invention provides a crystal of 1-{2-[(3S,4R)-1-[(3R... |
|
2018
|
Invention
|
Disubstituted 1, 2, 4-triazine compound. This invention provides a novel disubstituted 1,2,4-tria... |
|
2017
|
Invention
|
Method for producing triazine compound. The present invention provides an industrially advantageo... |
|
|
Invention
|
4-alkoxy-3-(trifluoromethyl)benzyl alcohol production method. The present invention relates to a ... |
|
2016
|
Invention
|
Bicyclic heterocyclic compound. Provided are a novel compound having a superior inhibitory action... |
|
|
Invention
|
Nitrogen-containing aromatic heterocyclic compound. 3 represents a hydrogen atom or an alkyl grou... |
|
|
Invention
|
Tablets containing a 1-(β-d-glucopyranosyl)-3-(phenylthienylmethyl)benzene compound. The present ... |
|
2015
|
Invention
|
Pyrrolidine compound and application as melanocortin receptor agonist. 4 are terminally attached ... |
|
|
Invention
|
Bicyclic or tricyclic heterocyclic compound. The present invention provides a novel bicyclic or t... |
|
|
Invention
|
Agent for preventing and/or treating ophthalmologic diseases. It is an object of the present inve... |
|
2011
|
Invention
|
Crystalline form of 1-(β-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene... |
|
2010
|
Invention
|
Plastic container comprising cyclic polyolefin layer. The present invention provides and a plasti... |
|
2009
|
Invention
|
Substituted heteroaryl pyridopyrimidone derivatives. A pyrimidone derivative represented by formu... |
|
2008
|
Invention
|
Process for the preparation of compounds useful as inhibitors of sglt. The present invention is d... |
|
2007
|
Invention
|
Crystalline form of 1-(β-d-glucopyransoyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzen... |
|
2006
|
Invention
|
Amine compound and use thereof for medical purposes. A novel amine compound represented by the fo... |
|
|
Invention
|
Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides. This invention relat... |
|
|
Invention
|
Substituted fused heterocyclic c-glycosides. This invention relates to substituted fused heterocy... |
|
|
Invention
|
O-glucosides. Substituted indazole-O-glucosides, compositions containing them, and methods of usi... |
|
2005
|
Invention
|
Glucopyranoside compound. A compound of the formula:
a pharmaceutically acceptable salt thereof... |
